Skip to main content
Contact Us
Subscribe
E-Edition
38°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pharvaris N.V.
(NQ:
PHVS
)
22.36
-1.81 (-7.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pharvaris N.V.
< Previous
1
2
3
Next >
PHVS Stock Earnings: Pharvaris Beats EPS for Q2 2024
August 14, 2024
PHVS stock results show that Pharvaris beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
July 16, 2024
Biogen has $8 billion to $10 billion in dry powder for acquisitions. Here are three names the company could examine.
Via
Investor's Business Daily
PHVS Stock Earnings: Pharvaris Misses EPS for Q1 2024
May 08, 2024
PHVS stock results show that Pharvaris missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
PHVS Stock Earnings: Pharvaris Misses EPS for Q4 2023
April 10, 2024
PHVS stock results show that Pharvaris missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Top-Notch Pharvaris Eyes Profit-Taking Zone On A Key FDA Decision
January 22, 2024
The company is working on a treatment for swelling attacks associated with a genetic disease.
Via
Investor's Business Daily
Exposures
Product Safety
FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps
January 22, 2024
Pharvaris receives FDA approval to advance deucrictibant for hereditary angioedema prophylaxis, lifting clinical hold. Learn about the latest developments in HAE treatment.
Via
Benzinga
Exposures
Product Safety
Analyst Expectations for Pharvaris's Future
December 07, 2023
Via
Benzinga
8 Analysts Have This to Say About Pharvaris
August 15, 2023
Via
Benzinga
Analyst Expectations for Pharvaris's Future
July 17, 2023
Via
Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.
Via
Benzinga
Turnaround For Pharvaris Since FDA Clinical Hold - Data Shows Its Oral Hereditary Angioedema Treatment Cuts Attacks
December 06, 2023
Pharvaris NV (NASDAQ: PHVS) released topline data from the CHAPTER-1 Phase 2 study meeting its primary endpoint, with deucrictibant demonstrating statistically significant and clinically meaningful...
Via
Benzinga
Exposures
Product Safety
Why Shares of Pharvaris N.V. Are Up Tuesday
June 27, 2023
Promising news from the Food and Drug Administration spurred the healthcare stock's rise.
Via
The Motley Fool
5 Analysts Have This to Say About Pharvaris
June 26, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Pharvaris
April 06, 2023
Via
Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
December 06, 2023
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
AMD Stock Alert: What to Expect From Advanced Micro Devices ‘Advancing AI’ Event
December 06, 2023
Advanced Micro Devices stock is climbing higher on Wednesday as AMD investors prepare for the company's Advancing AI event today.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Shopify (SHOP) Stock Falls Following Analyst Downgrade
December 06, 2023
Shopify stock is taking a beating on Wednesday after shares of SHOP were hit with a downgrade from Wedbush analyst Scott Devitt.
Via
InvestorPlace
Why Is Pharvaris (PHVS) Stock Up 36% Today?
December 06, 2023
Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants.
Via
InvestorPlace
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pharvaris' Promising Oral Treatment Solutions For Treating Swollen Blood Vessels - Analyst Sees 35% Upside
September 25, 2023
Wedbush has initiated coverage on Pharvaris N.V. (NASDAQ: PHVS), noting that the company stands out as one of the players with their strategy to develop and advance oral therapeutic options in both the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
September 11, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording losses in today’s session. IHS Holding Limited (NYSE: IHS) shares fell 15.7% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
August 18, 2023
U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
Via
Benzinga
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
August 15, 2023
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Removes Clinical Hold Of Pharvaris' Deucrictibant For On-Demand Treatment Of HAE
June 26, 2023
Pharvaris NV (NASDAQ: PHVS) announced that the FDA lifted the clinical hold on the Investigational New Drug (IND) application for deucrictibant (PHA-121) for the on-demand
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 12, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.